Salarius Pharmaceuticals Inc [NASDAQ: SLRX] closed the trading session at $0.63.
The stocks have a year to date performance of -66.03 percent and weekly performance of -13.50 percent. The stock has been moved at -60.44 percent over the last six months. The stock has performed -26.44 percent around the most recent 30 days and changed -31.31 percent over the most recent 3-months.
If compared to the average trading volume of 210.51K shares, SLRX reached to a volume of 8357827 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Salarius Pharmaceuticals Inc [SLRX]:
Ladenburg Thalmann have made an estimate for Salarius Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 27, 2020.
The Average True Range (ATR) for Salarius Pharmaceuticals Inc is set at 0.06 The Price to Book ratio for the last quarter was 21.03, with the Price to Cash per share for the same quarter was set at 0.85.
SLRX stock trade performance evaluation
Salarius Pharmaceuticals Inc [SLRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.50. With this latest performance, SLRX shares dropped by -26.44% in over the last four-week period, additionally sinking by -60.44% over the last 6 months – not to mention a drop of -82.57% in the past year of trading.
Salarius Pharmaceuticals Inc [SLRX]: An insightful look at the core fundamentals
Salarius Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.89 and a Current Ratio set at 0.89.
